RIYADH: Saudi-based Tabuk Pharmaceutical Manufacturing Company has announced an exclusive agreement with Leosons Overseas Corporation to manufacture and sell Leosons products in the MENA region, The agreement gives Tabuk Pharmaceutical an immediate take over of the US-based company"s existing business in more than 10 markets, with future expansion plans to include new regions and products. Tabuk Pharmaceutical will have the right to register, manufacture, and commercialize a range of 14 brands in several countries in the MENA region, according to the agreement. "We consider this partnership a step forward towards augmenting our plans for long-term growth and strengthening Tabuk’s over the counter business with direct contact with patients,” Wisam Alkhatib, vice president of Strategy and Business Development at Tabuk Pharmaceuticals said. “We believe our partnership with Tabuk Pharmaceuticals is transformational especially in Saudi Arabia,” John L. Ohanian, President of Leosons said.